Target intelligence / Profile preview

Tumor necrosis factor alpha mRNA (TNF-α mRNA)

Target
TNF-α mRNA
Molecular classification
Messenger RNA (mRNA), Other
01

Overview

Tumor necrosis factor alpha mRNA is the messenger RNA transcribed from the TNF gene, which is primarily expressed in immune cells such as macrophages. It encodes the cytokine TNF-α, a central mediator of inflammation and immune responses. The stability and translation of TNF-α mRNA are tightly regulated by sequence motifs, especially AU-rich elements in the 3' untranslated region, which bind proteins that promote rapid mRNA degradation in resting cells, and increase mRNA stability in activated cells. Therapeutically, TNF-α mRNA is rarely the direct target; instead, current drugs predominantly inhibit the TNF-α protein. However, research efforts occasionally focus on suppressing TNF-α mRNA using RNA interference or antisense molecules, though these are not standard clinical approaches.

Other names
TNF-alpha mRNATumor necrosis factor mRNATNF mRNA
02

Mechanism of action

Inhibition of TNF-α mRNA leads to decreased TNF-α protein synthesis, reducing inflammation or immune response

03

Biological functions

Encodes TNF-α proteinRegulates TNF-α production via post-transcriptional control (e.g., mRNA stability, translation efficiency)
04

Disease associations

Inflammation (through its product TNF-α)Cancer (through its product TNF-α)Autoimmune disease (through its product TNF-α)
05

Safety considerations

Off-target effects from mRNA-directed therapiesUnintended interference with global mRNA metabolism or immune activation if delivery vehicles improperly activate innate immunity (e.g., via TLRs)
06

Interacting drugs

Experimental: antisense oligonucleotides

2 more in the full profile.

07

Biomarkers

TNF-α mRNA levels (sometimes measured as a research biomarker of inflammatory activity or response to anti-inflammatory therapies)

Beyond the preview

Go deeper on Tumor necrosis factor alpha mRNA (TNF-α mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor necrosis factor alpha mRNA (TNF-α mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call